Drug Resistance in Breast Cancer Cells: Biophysical Characterization of and Doxorubicin Interactions with Membrane Lipids-Reference-Cited by-同舟云学术

Drug Resistance in Breast Cancer Cells: Biophysical Characterization of and Doxorubicin Interactions with Membrane Lipids

Published:2010-11-11 Issue:6 Volume:7 Page:2334-2348
ISSN:1543-8384
Container-title:Molecular Pharmaceutics
language:en
Short-container-title:Mol. Pharmaceutics

Author:

Peetla Chiranjeevi¹,Bhave Radhika¹,Vijayaraghavalu Sivakumar¹,Stine Andrew¹,Kooijman Edgar¹,Labhasetwar Vinod¹

Affiliation:

1. Department of Biomedical Engineering, Lerner Research Institute, Cleveland Clinic, Cleveland, Ohio 44195, United States, Department of Biological Sciences, Kent State University, Kent, Ohio 44240, United States, and Taussig Cancer Institute, Cleveland Clinic, Cleveland, Ohio 44195, United States

Publisher

American Chemical Society (ACS)

Subject

Drug Discovery,Pharmaceutical Science,Molecular Medicine

Link

https://pubs.acs.org/doi/pdf/10.1021/mp100308n

Reference53 articles.

1. Biophysical Interactions with Model Lipid Membranes: Applications in Drug Discovery and Drug Delivery

2. Drug interactions with lipid membranes

3. Lipids as a Target for Drugs Modulating Multidrug Resistance of Cancer Cells

4. Membrane effects of the antitumor drugs doxorubicin and thaliblastine: comparison to multidrug resistance modulators verapamil and trans-flupentixol

Cited by 120 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Phosphatidylserine-targeting bis(zinc-dipicolylamine) farnesol inhibits ATP production in cancer cells to overcome multidrug resistance;Supramolecular Materials;2024-12

2. Targeted nanomedicine modulating intercellular communications to arrest renal cell carcinoma progression;Journal of Drug Delivery Science and Technology;2024-09

3. Cyclic tachyplesin I kills proliferative, non-proliferative and drug-resistant melanoma cells without inducing resistance;Pharmacological Research;2024-09

4. Hyaluronic acid nanoparticles for targeted oral delivery of doxorubicin: Lymphatic transport and CD44 engagement;International Journal of Biological Macromolecules;2024-07

5. Insights into Transfer of Supramolecular Doxorubicin/Congo Red Aggregates through Phospholipid Membranes;Molecules;2024-05-30